MACKENZIE WARNER: Open Payments
NPI 1982201091 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 18 payments from 9 companies in 2025. Trend: 2023 $1,692 · 2024 $1,354 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 6 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $137 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| CSL Behring | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Biogen, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Xhance, CUVITRU, NEFFY, Hizentra, MOUNJARO, SPINRAZA, DUPIXENT, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
